The Patent Finder

Lumos Pharma, Inc.

Also on record
Records under this name other than the patents Lumos Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 7 of 7 · Back to Lumos Pharma, Inc.

PatentTitleStatus Expires Confidence
US 10,493,062Synthesis of cyclocreatine and analogs thereof
Lapsed on the fee record
Ended Dec 3, 2023 · From the USPTO record
Lapsed on the fee recordEnded Dec 3, 2023From the USPTO record
US 7,998,486Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
Lapsed on the fee record
Ended Aug 16, 2023 · From the USPTO record
Lapsed on the fee recordEnded Aug 16, 2023From the USPTO record
US 10,377,721Synthesis of cyclocreatine and analogs thereof
Lapsed on the fee record
Ended Aug 13, 2023 · From the USPTO record
Lapsed on the fee recordEnded Aug 13, 2023From the USPTO record
US 8,916,169Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
Lapsed on the fee record
Ended Dec 23, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 23, 2022From the USPTO record
US 10,081,605Synthesis of cyclocreatine and analogs thereof
Lapsed on the fee record
Ended Sep 25, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 25, 2022From the USPTO record
US 8,357,777Enhanced immunogenicity of tumor associated antigens by addition of αgal epitopes
Lapsed on the fee record
Ended Jan 22, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jan 22, 2021From the USPTO record
US 9,512,158Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
Lapsed on the fee record
Ended Dec 6, 2020 · From the USPTO record
Lapsed on the fee recordEnded Dec 6, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited